![Logo of OpenAlex.org Project OpenAlex Citations Logo](https://www.oahelper.org/wp-content/plugins/oahelper-citations/img/logo-openalex.jpg)
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Theranostic cells: emerging clinical applications of synthetic biology
Monica P. McNerney, Kailyn E. Doiron, Tai L. Ng, et al.
Nature Reviews Genetics (2021) Vol. 22, Iss. 11, pp. 730-746
Open Access | Times Cited: 78
Monica P. McNerney, Kailyn E. Doiron, Tai L. Ng, et al.
Nature Reviews Genetics (2021) Vol. 22, Iss. 11, pp. 730-746
Open Access | Times Cited: 78
Showing 1-25 of 78 citing articles:
Engineering bacteria as interactive cancer therapies
Candice R. Gurbatri, Nicholas Arpaia, Tal Danino
Science (2022) Vol. 378, Iss. 6622, pp. 858-864
Open Access | Times Cited: 182
Candice R. Gurbatri, Nicholas Arpaia, Tal Danino
Science (2022) Vol. 378, Iss. 6622, pp. 858-864
Open Access | Times Cited: 182
Emerging strategies for engineering Escherichia coli Nissle 1917-based therapeutics
Jason P. Lynch, Lisa Goers, Cammie F. Lesser
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 9, pp. 772-786
Open Access | Times Cited: 94
Jason P. Lynch, Lisa Goers, Cammie F. Lesser
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 9, pp. 772-786
Open Access | Times Cited: 94
Engineered Escherichia coli for the in situ secretion of therapeutic nanobodies in the gut
Jason P. Lynch, Coral González-Prieto, Analise Z. Reeves, et al.
Cell Host & Microbe (2023) Vol. 31, Iss. 4, pp. 634-649.e8
Open Access | Times Cited: 63
Jason P. Lynch, Coral González-Prieto, Analise Z. Reeves, et al.
Cell Host & Microbe (2023) Vol. 31, Iss. 4, pp. 634-649.e8
Open Access | Times Cited: 63
Game changers in science and technology - now and beyond
Ulrich A. K. Betz, Loukik Arora, R.A. Assal, et al.
Technological Forecasting and Social Change (2023) Vol. 193, pp. 122588-122588
Open Access | Times Cited: 61
Ulrich A. K. Betz, Loukik Arora, R.A. Assal, et al.
Technological Forecasting and Social Change (2023) Vol. 193, pp. 122588-122588
Open Access | Times Cited: 61
Cardiovascular disease therapeutics via engineered oral microbiota: Applications and perspective
Wenyu Zhen, Zifei Wang, Qing Wang, et al.
iMeta (2024) Vol. 3, Iss. 3
Open Access | Times Cited: 54
Wenyu Zhen, Zifei Wang, Qing Wang, et al.
iMeta (2024) Vol. 3, Iss. 3
Open Access | Times Cited: 54
Digital health: trends, opportunities and challenges in medical devices, pharma and bio-technology
Naresh Kasoju, N.S. Remya, Renjith Sasi, et al.
CSI Transactions on ICT (2023) Vol. 11, Iss. 1, pp. 11-30
Open Access | Times Cited: 51
Naresh Kasoju, N.S. Remya, Renjith Sasi, et al.
CSI Transactions on ICT (2023) Vol. 11, Iss. 1, pp. 11-30
Open Access | Times Cited: 51
Synthetic biology-inspired cell engineering in diagnosis, treatment, and drug development
Ninglin Zhao, Yingjie Song, Xiangqian Xie, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 37
Ninglin Zhao, Yingjie Song, Xiangqian Xie, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 37
There’s Plenty of Room Right Here: Biological Systems as Evolved, Overloaded, Multi-Scale Machines
Joshua Bongard, Michael Levin
Biomimetics (2023) Vol. 8, Iss. 1, pp. 110-110
Open Access | Times Cited: 36
Joshua Bongard, Michael Levin
Biomimetics (2023) Vol. 8, Iss. 1, pp. 110-110
Open Access | Times Cited: 36
Programmable synthetic receptors: the next-generation of cell and gene therapies
Fei Teng, Tongtong Cui, Li Zhou, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 16
Fei Teng, Tongtong Cui, Li Zhou, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 16
Recent advances in developing active targeting and multi-functional drug delivery systems via bioorthogonal chemistry
Wenzhe Yi, Ping Xiao, Xiaochen Liu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 61
Wenzhe Yi, Ping Xiao, Xiaochen Liu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 61
Ferrocene-Based Drugs, Delivery Nanomaterials and Fenton Mechanism: State of the Art, Recent Developments and Prospects
Cátia Ornelas, Didier Astruc
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2044-2044
Open Access | Times Cited: 33
Cátia Ornelas, Didier Astruc
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2044-2044
Open Access | Times Cited: 33
Bacterial therapies at the interface of synthetic biology and nanomedicine
Jaeseung Hahn, Suwan Ding, Jongwon Im, et al.
Nature Reviews Bioengineering (2023) Vol. 2, Iss. 2, pp. 120-135
Closed Access | Times Cited: 33
Jaeseung Hahn, Suwan Ding, Jongwon Im, et al.
Nature Reviews Bioengineering (2023) Vol. 2, Iss. 2, pp. 120-135
Closed Access | Times Cited: 33
Microbiome and lung cancer: carcinogenic mechanisms, early cancer diagnosis, and promising microbial therapies
Weici Liu, Zheshun Pi, Xiaokun Wang, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 196, pp. 104322-104322
Closed Access | Times Cited: 6
Weici Liu, Zheshun Pi, Xiaokun Wang, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 196, pp. 104322-104322
Closed Access | Times Cited: 6
CCR5 and IL-12 co-expression in CAR T cells improves antitumor efficacy by reprogramming tumor microenvironment in solid tumors
Yonggui Tian, Liubo Zhang, Yu P, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 2
Open Access
Yonggui Tian, Liubo Zhang, Yu P, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 2
Open Access
Population-level amplification of gene regulation by programmable gene transfer
Hye-In Son, Grayson S. Hamrick, A Shende, et al.
Nature Chemical Biology (2025)
Closed Access
Hye-In Son, Grayson S. Hamrick, A Shende, et al.
Nature Chemical Biology (2025)
Closed Access
Advances in engineered bacteria vaccines for enhancing anti-cancer immunity
Wu Liu, Wenjing Chen, Yujie Cai, et al.
Microbiome Research Reports (2025) Vol. 4, Iss. 1
Open Access
Wu Liu, Wenjing Chen, Yujie Cai, et al.
Microbiome Research Reports (2025) Vol. 4, Iss. 1
Open Access
Synthetic Biology‐Based Engineering Cells for Drug Delivery
Wenzhe Yi, Songnian Hu, Xindi Qian, et al.
Exploration (2025)
Open Access
Wenzhe Yi, Songnian Hu, Xindi Qian, et al.
Exploration (2025)
Open Access
Delivering living medicines with biomaterials
Tetsuhiro Harimoto, Wei‐Hung Jung, David Mooney
Nature Reviews Materials (2025)
Closed Access
Tetsuhiro Harimoto, Wei‐Hung Jung, David Mooney
Nature Reviews Materials (2025)
Closed Access
Bacterial two-component systems as sensors for synthetic biology applications
John T. Lazar, Jeffrey J. Tabor
Current Opinion in Systems Biology (2021) Vol. 28, pp. 100398-100398
Open Access | Times Cited: 49
John T. Lazar, Jeffrey J. Tabor
Current Opinion in Systems Biology (2021) Vol. 28, pp. 100398-100398
Open Access | Times Cited: 49
Biosynthetic neoantigen displayed on bacteria derived vesicles elicit systemic antitumour immunity
Fanqiang Meng, Liyan Li, Zhirang Zhang, et al.
Journal of Extracellular Vesicles (2022) Vol. 11, Iss. 12
Open Access | Times Cited: 32
Fanqiang Meng, Liyan Li, Zhirang Zhang, et al.
Journal of Extracellular Vesicles (2022) Vol. 11, Iss. 12
Open Access | Times Cited: 32
Microbiome engineering: engineered live biotherapeutic products for treating human disease
Jack W. Rutter, Linda Dekker, Kimberley A. Owen, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 26
Jack W. Rutter, Linda Dekker, Kimberley A. Owen, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 26
In situ immunomodulation of tumors with biosynthetic bacteria promote anti-tumor immunity
Lin Zhong-da, Fanqiang Meng, Yumeng Ma, et al.
Bioactive Materials (2023) Vol. 32, pp. 12-27
Open Access | Times Cited: 18
Lin Zhong-da, Fanqiang Meng, Yumeng Ma, et al.
Bioactive Materials (2023) Vol. 32, pp. 12-27
Open Access | Times Cited: 18
DNAGPT: A Generalized Pre-trained Tool for Multiple DNA Sequence Analysis Tasks
Daoan Zhang, Weitong Zhang, Yu Zhao, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 17
Daoan Zhang, Weitong Zhang, Yu Zhao, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 17
Decoding the microbiome: advances in genetic manipulation for gut bacteria
Ziying Chen, Wen‐Bing Jin, Alex Hoover, et al.
Trends in Microbiology (2023) Vol. 31, Iss. 11, pp. 1143-1161
Closed Access | Times Cited: 15
Ziying Chen, Wen‐Bing Jin, Alex Hoover, et al.
Trends in Microbiology (2023) Vol. 31, Iss. 11, pp. 1143-1161
Closed Access | Times Cited: 15
Synthetic bacterial therapies for intestinal diseases based on quorum-sensing circuits
Zhuoce Dang, Mengxue Gao, Lina Wang, et al.
Biotechnology Advances (2023) Vol. 65, pp. 108142-108142
Open Access | Times Cited: 14
Zhuoce Dang, Mengxue Gao, Lina Wang, et al.
Biotechnology Advances (2023) Vol. 65, pp. 108142-108142
Open Access | Times Cited: 14